CIK: 1571469 - Address: C/O Iovance Biotherapeutics, Inc., 825 Industrial Road, Suite 400, San Carlos, CA 94070
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/11/22 18:07
2/9/22
TPTXTurning Point Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCountouriotis AthenaCADOP,CEOS.d-10836.300-3-3110D
2/11/21 20:28
2/9/21
TPTXTurning Point Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCountouriotis AthenaCADOP,CEOM.dm1923.2006050D
2/11/21 20:28
2/9/21
TPTXTurning Point Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCountouriotis AthenaCADOP,CEOS.dm-8,249137.480-60-5450D
5/26/20 17:55
5/21/20
TPTXTurning Point Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCountouriotis AthenaCADOP,CEOP25060.00041827D
3/25/20 20:26
3/24/20
PASGPassage Bio, Inc.DEHealthBioPrdBiological Products, (No DiagCountouriotis AthenaPADP15014.9801011219D
3/3/20 18:37
3/3/20
PASGPassage Bio, Inc.DEHealthBioPrdBiological Products, (No DiagCountouriotis AthenaPADP16018.0009New9D
9/11/19 16:15
9/10/19
TPTXTurning Point Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCountouriotis AthenaCADOP,CEOP45045.000108322D
4/24/19 17:55
4/22/19
TPTXTurning Point Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCountouriotis AthenaCADOP,CEOP21618.00012New12D
2/6/17 19:01
2/3/17
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagCountouriotis AthenaCAOSVP,ChieM.d00.0029189039D-114820471484601414
1/9/17 16:03
1/5/17
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagCountouriotis AthenaCAOSVP,ChieM.d00.002883827D7-1147106193034-9-21-15-12
7/5/16 16:55
6/30/16
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagCountouriotis AthenaCAOSVP,ChieM.d00.001464820D-9-59-47-100561246163915
1/7/16 17:25
1/5/16
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagCountouriotis AthenaCAOSVP,ChieM.d00.0016812214D857-2611-11-1-8-9-1-31-45-25-37-15

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact